A study to assess the Patient navigation and symptom reporting with patient reported outcome in lung cancer patient.
Phase 3
- Conditions
- Health Condition 1: C399- Malignant neoplasm of lower respiratory tract, part unspecified
- Registration Number
- CTRI/2020/02/023511
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Suspected/diagnosed lung cancer patient
2.Planned for palliative intent therapy at Tata Memorial Center
3.Willing to give written informed consent
Exclusion Criteria
None
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Functional Assessment of Cancer Therapyâ??Lung (FACT-L) Quality of Life <br/ ><br>measureTimepoint: FACT & QOL at Baseline & every 12 weeks. <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1. Time to initiation of cancer treatment. 2.treatment completion <br/ ><br> 3. progression-free survival <br/ ><br>4. number of emergency visits or unplanned visits, <br/ ><br>dose intensity <br/ ><br>5.time to deterioration of ECOG performance status, <br/ ><br>6. Treatment adherence <br/ ><br>7. symptom control between the two arms <br/ ><br>8.percentage survival <br/ ><br>9.overall survival (OS). <br/ ><br>Timepoint: 1. At Initiation <br/ ><br>2. At end of 4 cycles or 3 months <br/ ><br>3. PFE at Progression <br/ ><br>4. At progression <br/ ><br>5. At Progression <br/ ><br>6. At Progression <br/ ><br>7. At Progression <br/ ><br>8. At 1 year <br/ ><br>9. At death <br/ ><br> <br/ ><br>